As Moderna maps out a more cautious future amid lower-than-expected sales of its current products, the company is bolstering ...

WALTHAM, Mass., Jan. 15, 2025 /PRNewswire/ -- Accelerated Cure Project (ACP) for Multiple Sclerosis (MS) with generous support from EMD Serono's Embracing Caregivers initiative, announced today ...

Randomized Comparison of Magnetic Resonance Imaging Versus Transurethral Resection for Staging New Bladder Cancers: Results From the Prospective BladderPath Trial Over the past 15 years, the landscape ...

It was formerly known as Serono SA and changed its name to Merck Serono S.A. in January 2007. The company was founded in 1987 and is headquartered in Darmstadt, Germany with locations in Africa, Asia, ...

Patients with bladder cancer in Scotland will be the first in the UK to claim access to maintenance treatment with Merck Serono and Pfizer's Bavencio, ahead of their counterparts in England and Wales.

Merck KGaA and Pfizer PD-L1 inhibitor Bavencio has missed the mark in its second ovarian cancer trial in a month, this time failing in previously-untreated patients.

Counterfeits of the Serono product have been found in California, Ohio, Kentucky, Michigan, New Jersey, Florida, and Missouri. "Since it's in such a scattered distribution, we assume it's in other ...